SCHEMBL484287

SCHEMBL484287

Cc1cccc(Cl)c1C(=O)NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5ccccc5C#N)CC4)C3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.39
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
CXCR3 P49682 1/20 0.36
TAS1R3 Q7RTX0 3/20 0.36
TAS1R1 Q7RTX1 3/20 0.36
TAS1R2 Q8TE23 3/20 0.36
ACKR3 P25106 1/20 0.35
CYP2D6 P10635 3/20 0.35
USP2 O75604 2/20 0.35
CYP3A4 P08684 2/20 0.35
DDR1 Q08345 1/20 0.35
CCR8 P51685 1/20 0.34
KCNH2 Q12809 1/20 0.34
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
CCR5 P51681 1/20 0.34
KDM1A O60341 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485343 0.92 CYP2D6 (0.40) ARMEN1LMNAKMT2ACXCR3
SCHEMBL484329 0.90 TAS1R3 (0.42) ARCXCR3TAS1R3TAS1R1TAS1R2
SCHEMBL484493 0.89 CYP3A4 (0.48) MEN1KMT2ACYP2D6USP2CYP3A4
SCHEMBL485024 0.89 TAS1R3 (0.42) ARCXCR3TAS1R3TAS1R1TAS1R2
SCHEMBL484600 0.88 CYP3A4 (0.41) MEN1KMT2ACXCR3ACKR3CYP2D6
SCHEMBL484491 0.88 CYP2D6 (0.44) MEN1LMNAKMT2ACXCR3TAS1R3
SCHEMBL2819251 0.86 CYP2D6 (0.40) LMNACYP2D6USP2CYP3A4CYP1A2
SCHEMBL485059 0.85 TAS1R3 (0.43) ARCXCR3TAS1R3TAS1R1TAS1R2
SCHEMBL2817168 0.85 ALPI (0.40) MEN1LMNAPOLBKMT2ATAS1R3
SCHEMBL484502 0.85 ACHE (0.42) POLBACKR3CYP2D6CYP3A4DDR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN AR 219/4885MEN1 901/4885LMNA 1187/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN AR 219/4885MEN1 901/4885LMNA 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.